VS BioClinical SRL
VS BioClinical reported total assets of 644,383 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Apr 2026).
The score of VS BioClinical shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +59 % Total assets +91 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VS BioClinical's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 178,073 € | ||||
| Equity | 463,776 € | ||||
| Cash | 79,111 € | ||||
| EBITDA | 237,296 € | ||||
| Total assets | 644,383 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Apr 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
- Year ended 31 Dec 2022filed on 19 Jun 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
VS BioClinical's financial analysis
- Solvency72.0%sector median: 66.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VS BioClinical
VS BioClinical's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0757.634.336
- VAT number
- BE0757634336
- Peppol
- Registered · 0208:0757634336 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Oct 2020
- Registered office
- 4420 Saint-Nicolas
- Latest accounts
- 2025 · filed on 08 Apr 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
VS BioClinical (SRL) has been based in Saint-Nicolas since 2020, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 178,073 € and equity of 463,776 €; its revenue is not published. Its solvency stands at 72.0%, above the median of its sector (66.2%).
Companies similar to VS BioClinical
Companies in the same business, of comparable size and area, outside its group.
- Cantal Hoeilaart · balance sheet 526,206 €
- Immoma Meise · balance sheet 644,261 €
- Sagret Manufacture of plastics in primary forms Antwerp · balance sheet 643,674 €
- Macros Repair and maintenance of fabricated metal products Brussels · balance sheet 643,648 €
- Mcng Invest Charleroi · balance sheet 644,957 €
Frequently asked questions about VS BioClinical
What is the revenue of VS BioClinical?
VS BioClinical files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of VS BioClinical?
In Belgium, the VAT number is the company number prefixed with BE: BE0757634336 for VS BioClinical, if the company is VAT-registered. Its company number (CBE) is 0757.634.336.
Where is the registered office of VS BioClinical?
According to the CBE register, the registered office of VS BioClinical is in 4420 Saint-Nicolas.
What is the equity of VS BioClinical?
At the close of the 2025 financial year, the equity of VS BioClinical amounts to 463,776 €, a solvency of 72.0% of total assets.
Who manages VS BioClinical?
The register lists 1 active mandates at VS BioClinical. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of VS BioClinical
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →